AAAAAA

   
Results: 1-11 |
Results: 11

Authors: NARDONE L MARMIROLI L SALVI G GUIDI C GENTILE P ZICCARELLI P GENOVESI D NIESPOLO RM AUSILICEFARO G
Citation: L. Nardone et al., ANTHRACYCLINES, VINORELBINE (V) AND HIGH-DOSE TAMOXIFEN (T) IN METASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 389-389

Authors: MARMIROLI L ZICCARELLI P NARDONE L GENTILE P SALVI G GENOVESI D GUIDI C NIESPOLO RM AUSILICEFARO G
Citation: L. Marmiroli et al., PACLITAXEL (P) AS A 5-DAY CONTINUOUS-INFUSION IN RECURRED HEAD AND NECK-CANCER - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 399-399

Authors: AUSILICEFARO G MARMIROLI L
Citation: G. Ausilicefaro et L. Marmiroli, SUPPORTIVE CARE IN RADIOTHERAPY - A REVIEW, Tumori, 84(2), 1998, pp. 107-111

Authors: NARDONE L SALVI G MARMIROLI L ROSETTO ME MARUCCI L AUSILICEFARO G
Citation: L. Nardone et al., A NEW ACTIVE COMBINATION OF TAMOXIFEN (T)-VINORELBINE (V)-ANTHRACICLINES IN METASTATIC BREAST-CANCER (MBC), European journal of cancer, 33, 1997, pp. 712-712

Authors: FORNI F ZUPPI C ANTENUCCI M AUSILICEFARO G MARMIROLI L FIORENTINO G GIARDINA B
Citation: F. Forni et al., BIOCHEMICAL MARKERS OF TUBULAR FUNCTION IN PATIENTS RECEIVING CONTINUOUS CARBOPLATIN INFUSION, Clinical chemistry, 42(9), 1996, pp. 1498-1499

Authors: OLMI P AUSILICEFARO G
Citation: P. Olmi et G. Ausilicefaro, CANCER IN THE ELDERLY - ANALYSIS OF 2061 PATIENTS AGED 70 AND OVER REFERRED TO RADIOTHERAPY CENTERS IN ITALY IN 1994, European journal of cancer, 31A, 1995, pp. 172-172

Authors: AUSILICEFARO G MARMIROLI L FINCATO G NARDONE L SCAPATI AM ANDRULLI AD GENOVESI D SALVI G
Citation: G. Ausilicefaro et al., COMPARISON BETWEEN RHGM-CSF AND RHG-CSF ADMINISTERED DURING RADIOTHERAPY AND AFTER PROLONGED CARBOPLATIN INFUSION IN PREVENTING LEUKOPENIA AND MUCOSYTES PRODUCED BY CHEMORADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER, European journal of cancer, 31A, 1995, pp. 255-255

Authors: MARMIROLI L NARDONE L SALVI G FIORENTINO G SCAPATI AM GENOVESI D AUSILICEFARO G
Citation: L. Marmiroli et al., 14 OR 21 CONSECUTIVE DAYS INFUSION OF CARBOPLATIN (CBDCA) AND CONCOMITANT RADIOTHERAPY (RT) IN ADVANCED HEAD AND NECK-CANCER (HNC) - FINAL REPORT OF A FEASIBILITY STUDY, European journal of cancer, 31A, 1995, pp. 417-417

Authors: AUSILICEFARO G NARDONE L SALVI G TERRIBILE D BELLANTONE R ANDRULLI AD CARBONE A FEDERICO E PASTORE G MARMIROLI L
Citation: G. Ausilicefaro et al., EVALUATION OF BIOLOGICAL FACTORS AFTER PRIMARY RADIOTHERAPY IN OPERABLE (LARGE T2 AND T3) BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 1041-1041

Authors: AUSILICEFARO G MARMIROLI L NARDONE L SALVI G
Citation: G. Ausilicefaro et al., PROLONGED CONTINUOUS-INFUSION OF CARBOPLATIN AND CONCOMITANT RADIOTHERAPY IN ADVANCED HEAD AND NECK-CANCER - A PHASE-I STUDY, American journal of clinical oncology, 18(3), 1995, pp. 273-276

Authors: MASTRANGELO R LASORELLA A RICCARDI R COLOSIMO C IAVARONE A TORNESELLO A MASTRANGELO S AUSILICEFARO G DIROCCO C
Citation: R. Mastrangelo et al., CARBOPLATIN IN CHILDHOOD MEDULLOBLASTOMA PNET - FEASIBILITY OF AN IN-VIVO SENSITIVITY TEST IN AN UP-FRONT STUDY, Medical and pediatric oncology, 24(3), 1995, pp. 188-196
Risultati: 1-11 |